Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fathi Halaweish

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Chemical Biology & Drug Design|February 13, 2023
Estrone analogs as potential inhibitors targeting EGFR-MAPK pathway in non-small-cell lung cancerFelix Acheampong, Trevor Ostlund, Mater Mahnashi, et al.
Chemical Biology & Drug Design|July 27, 2023
Antiproliferation and apoptosis studies of estrone pharmacophores in triple-negative breast cancerFelix Acheampong, Trevor Ostlund, Mater Mahnashi, et al.
Bioorganic & Medicinal Chemistry|March 15, 2024
Synthesis and biological activity of 11-Oxygenated and heterocyclic estrone analogs in pancreatic cancer monolayers and 3D spheroidsKhaled Alseud, Trevor Ostlund, Mikhail Durymanov, et al.
Journal of Natural Products|August 23, 2003
Copacamphane, picrotoxane, and alloaromadendrane sesquiterpene glycosides and phenolic glycosides from Dendrobium moniliformeChunsheng Zhao, Qunfang Liu, Fathi Halaweish, et al.
Journal of Economic Entomology|July 17, 2025
Multicomponent attract-and-kill system for pest insects attacking cucurbit cropsAnna Wallingford, Ariela I Haber, Fathi Halaweish, et al.
Steroids|December 21, 2021
Triazole-estradiol analogs: A potential cancer therapeutic targeting ovarian and colorectal cancerTrevor Ostlund, Faez Alotaibi, Jennifer Kyeremateng, et al.
Drug Development Research|December 9, 2022
Novel EGFR-MAPK kinase and ABC transporter inhibitors for HepG2 resistant to ErlotinibTrevor Ostlund, Kakan SutraDhar, Sara M Elgazwi, et al.
Journal of Natural Products|March 11, 2015
Cucurbitacin D Is a Disruptor of the HSP90 Chaperone MachineryJessica A Hall, Sahithi Seedarala, Nichole Rice, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 6, 2015
Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin BFardous F El-Senduny, Farid A Badria, Ahmed M El-Waseef, et al.
Molecules (Basel, Switzerland)|February 13, 2025
Triazole-Estradiol Analogs Induce Apoptosis and Inhibit EGFR and Its Downstream Pathways in Triple Negative Breast CancerFelix Acheampong, Trevor Ostlund, Emily Hedge, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Chemical Biology & Drug Design|February 13, 2023
Estrone analogs as potential inhibitors targeting EGFR-MAPK pathway in non-small-cell lung cancerFelix Acheampong, Trevor Ostlund, Mater Mahnashi, et al.
Chemical Biology & Drug Design|July 27, 2023
Antiproliferation and apoptosis studies of estrone pharmacophores in triple-negative breast cancerFelix Acheampong, Trevor Ostlund, Mater Mahnashi, et al.
Bioorganic & Medicinal Chemistry|March 15, 2024
Synthesis and biological activity of 11-Oxygenated and heterocyclic estrone analogs in pancreatic cancer monolayers and 3D spheroidsKhaled Alseud, Trevor Ostlund, Mikhail Durymanov, et al.
Journal of Natural Products|August 23, 2003
Copacamphane, picrotoxane, and alloaromadendrane sesquiterpene glycosides and phenolic glycosides from Dendrobium moniliformeChunsheng Zhao, Qunfang Liu, Fathi Halaweish, et al.
Journal of Economic Entomology|July 17, 2025
Multicomponent attract-and-kill system for pest insects attacking cucurbit cropsAnna Wallingford, Ariela I Haber, Fathi Halaweish, et al.
Steroids|December 21, 2021
Triazole-estradiol analogs: A potential cancer therapeutic targeting ovarian and colorectal cancerTrevor Ostlund, Faez Alotaibi, Jennifer Kyeremateng, et al.
Drug Development Research|December 9, 2022
Novel EGFR-MAPK kinase and ABC transporter inhibitors for HepG2 resistant to ErlotinibTrevor Ostlund, Kakan SutraDhar, Sara M Elgazwi, et al.
Journal of Natural Products|March 11, 2015
Cucurbitacin D Is a Disruptor of the HSP90 Chaperone MachineryJessica A Hall, Sahithi Seedarala, Nichole Rice, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 6, 2015
Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin BFardous F El-Senduny, Farid A Badria, Ahmed M El-Waseef, et al.
Molecules (Basel, Switzerland)|February 13, 2025
Triazole-Estradiol Analogs Induce Apoptosis and Inhibit EGFR and Its Downstream Pathways in Triple Negative Breast CancerFelix Acheampong, Trevor Ostlund, Emily Hedge, et al.
Pageof 2